TRIB News and Press, Trinity Biotech plc From 11/23/20

Gainers: Medigus (MDGS) +36%, 180 Life Sciences (ATNF) +35%, Graybug Vision (GRAY) +23%, Trinity Biotech (TRIB) +18%, Accuray (ARAY) +14%.Losers: Bellerophon Therapeutics (BLPH) -18%, BioLineRx (BLRX) -13%, AIM ImmunoTech (AIM) -11%, iBio...

Trinity Biotech plc (TRIB) Q3 2020 Earnings Conference Call November 17, 2020 11:00 ET Company Participants Kevin Tansley - Chief Financial Officer Ronan O'Caoimh - Chairman & Chief Executive Officer John Gillard - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti &...

Trinity Biotech (TRIB): Q3 Non-GAAP EPS of $0.36; GAAP EPS of $0.32 beats by $0.22.Revenue of $32.01M (+30.2% Y/Y) beats by $4.01M.Press Release For further details see: Trinity Biotech EPS beats by $0.22, beats on revenue

DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. Quarter 3 Resul...

DUBLIN, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter 2020 on Tuesday, November 17, 2020. The Compan...

Kaixin Auto Holdings (KXIN) +57%.Midatech Pharma plc (MTP) +42% after announcing positive results from a Phase I study evaluating MTX110.Front Yard Residential (RESI) +34% after announcing going private deal valued at ~$2.4B.ARC Document Solutions (ARC) +26% on prelim...

Trinity Biotech plc (TRIB) Q2 2020 Earnings Conference Call Aug 25, 2020, 11:00 AM ET Company Participants Kevin Tansley - CFO Ronan O'Caoimh - Chairman & CEO Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Jim Sidoti - Sidoti ...

Trinity Biotech ( TRIB +2.4% ) reports Q2 revenue of $16.02M ( -28.8% Y/Y ),  beating expectations by $3.02M. More news on: Trinity Biotech plc, Earnings news and commentary Read more ...

Trinity Biotech (NASDAQ: TRIB ) : Q2 GAAP EPSADR of $0.01. More news on: Trinity Biotech plc, Earnings news and commentary, Healthcare stocks news, , Read more ...

DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020. Quarter 2 Results &#x...